Compare GSK plc (GSK) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Shopify Inc. — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while Shopify Inc. trades at $170.85 (market cap $211.73B). The key difference: Shopify Inc. is far larger — about 2.3× GSK plc's market cap, and GSK plc pays a 3.9% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Shopify Inc. for 78 Days on average.
| GSK | SHOP | |
|---|---|---|
Market Cap | $91.88B | $211.73B |
Volume | 7,730,529 | 7,146,651 |
Sector | Health | Technology |
52-Week High | $61.18 | $179.01 |
52-Week Low | $43.24 | $95.40 |
Typical Hold Time | 93 Days | 78 Days |
Enterprise Value | $111.88B | $206.96B |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.54, down 1.02% with bearish technical signals but strong fundamentals including 29.73% ROE and consistent earnings beats. The company maintains robust profitability with 72.73% gross margins and is actively expanding its oncology pipeline through strategic partnerships. Recent developments include a $750M cancer therapy acquisition and advancing mRNA vaccine candidates.
GSK presents a mixed outlook with strong operational performance offset by technical weakness. Investment appeal lies in valuation multiples below industry averages and pipeline expansion, though risks include HIV patent expirations and manufacturing restructuring. Analyst consensus leans cautious with 55% hold ratings amid near-term headwinds.
Shopify (SHOP) trades at $164.54, down 0.84% on the day, with strong technical momentum showing bullish moving average signals despite overbought RSI readings. The company demonstrates robust revenue growth, with 2025 revenue reaching $11.56 billion and net income of $1.23 billion, though valuation metrics remain elevated with a P/E of 111. Recent developments include the launch of Canvas AI store-building tools and expanding payment services.
Shopify maintains strong growth trajectory with accelerating merchant solutions revenue and expanding AI capabilities. However, premium valuation multiples and competitive pressures from Amazon pose risks. Analyst consensus remains bullish with 67% buy ratings and $168.63 price target, suggesting modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
